Round Table Discussion: Transforming Therapeutic Pipelines with Appropriate Spatial Omics & Digital Pathology Workflows to Inform Discovery & Maximize Clinical Success

• Evaluating technologies based on research goals and available resources to ensure the right tools are employed at the right stage for maximum efficiency and impact
• Implementing spatial biology effectively into early R&D pipelines to unlock deeper understanding of pathology and target selection
• Translating findings through to the clinic with digital pathology to enhance patient selection and biomarker validation

Speakers:

Hua Gong

Vice President - Translational Medicine

BridgeBio Oncology Therapeutics